2026 NLA Clinical Consensus: Updated LDL and ApoB Targets in Familial Hypercholesterolemia
Catherine Benziger, Medical Director of Heart and Vascular Research at Essentia Health, Adjunct Associate Professor of Medicine at the University of Minnesota Medical School, shared Christopher Cannon’s post on LinkedIn, adding:
“Check out the new LDL and ApoB targets for FH patients.”
Christopher Cannon, Cardiologist at Brigham and Women’s Hospital, Editor-in-Chief of Harvard Heart Letter, shared a post on LinkedIn about a recent article by Zahid Ahmad et al. published in JAMA:
“2026 NLA clinical consensus document on Familial Hypercholesterolemia.”
Title: Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association
Authors: Zahid Ahmad, Anandita Agarwala, Marina Cuchel, P. Barton Duell, Robert A. Hegele, Lisa Hudgins, Allison Jamison, Dinesh Kalra, Amit Khera, Joshua W. Knowles, Iftikhar Kullo, Ana Morales, Mark A. Rothstein, Joseph J. Saseen, Daniel Soffer, Bruce A. Warden, William S. Weintraub, Lauren Williams, Anne C. Goldberg
Read the Full Article on JAMA:
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 10, 2026, 11:56William Pao: Celebrating a Landmark Breakthrough in Hemophilia Care
-
Sep 10, 2026, 11:25Andreas Glenthøj: New Sickle Cell Trait Data in UpToDate
-
Sep 10, 2026, 10:53A New Era of Hemophilia Screening and Diagnosis in Women and Girls – ISTH
-
Sep 10, 2026, 10:03Investing in Youth, Transforming Hemophilia Care – WFH
-
Sep 10, 2026, 09:51Ronke Oke BEM: 20 Years of Newborn Sickle Cell Screening in England
-
Sep 10, 2026, 09:41Seunghwan Song: Hemlibra and the Science That Changed Hemophilia A Care
-
Sep 10, 2026, 09:20Mark Dawson: A Radical Rethink of Hemophilia Treatment
-
Sep 10, 2026, 07:26Carly Newton: Every Donation Helps Save Lives
-
Sep 10, 2026, 07:152023 ACR/EULAR APS Classification Criteria – APS Foundation of America